Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women

Total Dose Infusion of Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women: a Randomized Controlled Trial

Iron deficiency is the most prevalent nutritional deficiency and the most common cause of anemia .It is characterized by a defect in hemoglobin synthesis, resulting in red blood cells that are abnormally small (microcytic) and contain a decreased amount of hemoglobin (hypochromic).

Inclusion Criteria:

• Hemoglobin < 10 g/dL
• Gestational age between 14-28 weeks.
• Willingness to participate and signing the informed consent form.

Exclusion Criteria:

• Iron overload or disturbances in utilization of iron
• Decompensated liver cirrhosis and active hepatitis
• Active acute or chronic infections
• History of multiple allergies
• Known hypersensitivity to parenteral iron or any recipients in the investigation drug products
• Erythropoietin treatment within 8 weeks prior to the screening visit
• Other iron treatment or blood transfusion within 4 weeks prior to the screening visit
• Planned elective surgery during the study.